Fluoroquinolones suppress gluconeogenesis by inhibiting fructose 1,6-bisphosphatase in primary monkey hepatocytes

被引:1
|
作者
Iguchi, Takuma [1 ]
Goto, Koichi [1 ]
Watanabe, Kyoko [2 ]
Hashimoto, Kazuyuki [2 ]
Suzuki, Takami [3 ]
Kishino, Hiroyuki [1 ]
Fujimoto, Kazunori [1 ]
Mori, Kazuhiko [1 ]
机构
[1] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, 1-16-13 Kita Kasai, Tokyo 1348630, Japan
[2] Daiichi Sankyo Co Ltd, Biomarker & Translat Res Dept, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1400005, Japan
[3] Daiichi Sankyo Co Ltd, Oncol Res Labs 1, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1400005, Japan
关键词
Gluconeogenesis; Fructose 1,6-bisphosphatase; Fluoroquinolones; Hepatocyte; Cynomolgus monkey; PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; GLUCOSE-METABOLISM; INSULIN-SECRETION; GATIFLOXACIN; FRUCTOSE-1,6-BISPHOSPHATASE; LEVOFLOXACIN; DYSGLYCEMIA; EXPRESSION; HEALTH; MODEL;
D O I
10.1016/j.tiv.2020.104786
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Dysglycemia is one of the most serious adverse events associated with the clinical use of certain fluoroquinolones. The purpose of this study was to investigate the effects of the representative fluoroquinolones moxifloxacin and gatifloxacin on hepatic gluconeogenesis using primary monkey hepatocytes. Glucose production was induced after the cells were incubated for 4 h with 10 mM sodium lactate and 1 mM sodium pyruvate as gluconeogenic substrates. Under these conditions, moxifloxacin and gatifloxacin dose-dependently suppressed gluconeogenesis at concentrations of 100 mu M or higher. Transcriptome analysis of rate-limiting enzymes involved in hepatic gluconeogenesis revealed that moxifloxacin and gatifloxacin at a concentration of 1000 mu M did not affect the expression of key gluconeogenic enzymes such as phosphoenolpyruvate carboxykinase, glucose 6-phosphatase, and fructose 1,6-bisphosphatase. Furthermore, metabolome analysis, in vitro glucose production assay using additional gluconeogenic substrates, and fructose 1,6-bisphosphatase assay using the cell extracts showed that fluoroquinolones enzymatically suppressed hepatic gluconeogenesis by inhibiting fructose 1,6-bisphosphatase. These inhibitory effects may involve in the clinically relevant dysglycemia associated with fluoroquinolones in human.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] REGULATION OF FRUCTOSE-1,6-BISPHOSPHATASE ACTIVITY IN PRIMARY CULTURED ASTROCYTES
    VERGE, V
    HEVOR, TK
    NEUROCHEMICAL RESEARCH, 1995, 20 (09) : 1049 - 1056
  • [32] Fructose-1,6-bisphosphatase genes in animals
    Tillmann, H
    Bernhard, D
    Eschrich, K
    GENE, 2002, 291 (1-2) : 57 - 66
  • [33] THE CHLOROPLAST FRUCTOSE 1,6-BISPHOSPHATASE STUDIED IN A MODEL SYSTEM
    SCHURMANN, P
    KOBAYASHI, Y
    EXPERIENTIA, 1983, 39 (06): : 654 - 654
  • [34] MODIFICATION OF YEAST FRUCTOSE-1,6-BISPHOSPHATASE
    POHLIG, G
    SCHAFER, W
    VONHERRATH, M
    HOLZER, H
    CURRENT TOPICS IN CELLULAR REGULATION, 1985, 27 : 317 - 325
  • [35] A Chinese Adult Patient with Fructose 1,6-bisphosphatase Deficiency
    Lu Jing-Ru
    Wang Cui
    Shao Le-Ping
    中华医学杂志英文版, 2017, 130 (16) : 2009 - 2010
  • [36] Fructose 1,6-bisphosphatase as a promising target of anticancer treatment
    Gizak, Agnieszka
    Budziak, Bartosz
    Domaradzka, Aleksandra
    Pietras, Lukasz
    Rakus, Dariusz
    ADVANCES IN BIOLOGICAL REGULATION, 2025, 95
  • [37] LOSS OF FRUCTOSE-1,6-BISPHOSPHATASE 1 IS CRITICAL CARCINOMA
    不详
    CANCER DISCOVERY, 2014, 4 (09) : 984 - 984
  • [38] FRUCTOSE 1,6-BISPHOSPHATASE IN SEEDS OF CORYLUS-AVELLANA
    LI, L
    ROSS, JD
    PHYTOCHEMISTRY, 1988, 27 (07) : 1977 - 1980
  • [39] AVIAN HEART FRUCTOSE 1,6-BISPHOSPHATASE - EMBRYONIC ENZYME
    HARRIS, W
    DAYS, R
    STALLWORTH, J
    JOHNSON, C
    HUBERT, C
    FINKELSTEIN, I
    REID, J
    JOHNSON, R
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1977, 75 (04) : 1122 - 1126
  • [40] EFFECT OF DIETHYLPYROCARBONATE ON SPINACH CHLOROPLAST FRUCTOSE -1,6-BISPHOSPHATASE
    GAY, GD
    WOLOSIUK, RA
    ANALES DE LA ASOCIACION QUIMICA ARGENTINA, 1989, 77 (01): : 19 - 25